Nothing Special   »   [go: up one dir, main page]

AU3683878A - Penicillanic acid 1,1-dioxides as beta-lactamase inhibitors - Google Patents

Penicillanic acid 1,1-dioxides as beta-lactamase inhibitors

Info

Publication number
AU3683878A
AU3683878A AU36838/78A AU3683878A AU3683878A AU 3683878 A AU3683878 A AU 3683878A AU 36838/78 A AU36838/78 A AU 36838/78A AU 3683878 A AU3683878 A AU 3683878A AU 3683878 A AU3683878 A AU 3683878A
Authority
AU
Australia
Prior art keywords
dioxides
beta
penicillanic acid
lactamase inhibitors
lactamase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU36838/78A
Other versions
AU513636B2 (en
Inventor
Wayne Ernest Barth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27122691&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU3683878(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of AU3683878A publication Critical patent/AU3683878A/en
Application granted granted Critical
Publication of AU513636B2 publication Critical patent/AU513636B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU36838/78A 1977-06-07 1978-06-02 Penicillanic acid 1,1-dioxides as beta-lactamase inhibitors Ceased AU513636B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US80432077A 1977-06-07 1977-06-07
US804320 1977-06-07
US87938178A 1978-02-21 1978-02-21
US879381 1978-02-21

Related Child Applications (3)

Application Number Title Priority Date Filing Date
AU48465/79A Addition AU514926B2 (en) 1977-06-07 1979-06-27 Combination of derivatives of pencillin and cephalosporan
AU64030/80A Division AU522487B2 (en) 1977-06-07 1980-10-31 Intermediate compounds to penicillanic and 11-dioxides
AU64031/80A Division AU522465B2 (en) 1977-06-07 1980-10-31 Intermediate compounds to penicillanic and 11-dioxides

Publications (2)

Publication Number Publication Date
AU3683878A true AU3683878A (en) 1979-12-06
AU513636B2 AU513636B2 (en) 1980-12-11

Family

ID=27122691

Family Applications (1)

Application Number Title Priority Date Filing Date
AU36838/78A Ceased AU513636B2 (en) 1977-06-07 1978-06-02 Penicillanic acid 1,1-dioxides as beta-lactamase inhibitors

Country Status (35)

Country Link
AR (1) AR224111A1 (en)
AT (2) AT360649B (en)
AU (1) AU513636B2 (en)
BE (1) BE867859A (en)
BG (2) BG34615A3 (en)
CH (1) CH634073A5 (en)
CS (1) CS208472B2 (en)
DD (2) DD148585A5 (en)
DE (2) DE2857263C3 (en)
DK (1) DK155740C (en)
EG (1) EG13869A (en)
FI (1) FI66003C (en)
FR (2) FR2393804A1 (en)
GB (1) GB2000138B (en)
GR (1) GR72255B (en)
HK (1) HK13184A (en)
HU (1) HU180042B (en)
IE (1) IE47079B1 (en)
IL (2) IL54867A (en)
IN (1) IN149747B (en)
IT (1) IT1096381B (en)
KE (1) KE3355A (en)
LU (1) LU79774A1 (en)
MY (1) MY8500092A (en)
NL (2) NL180009C (en)
NO (2) NO151746C (en)
NZ (1) NZ187476A (en)
OA (1) OA05964A (en)
PH (3) PH26810A (en)
PL (1) PL114501B1 (en)
PT (1) PT68146A (en)
SE (2) SE436206B (en)
SG (1) SG65383G (en)
SU (1) SU860706A1 (en)
YU (1) YU41829B (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU77306A1 (en) * 1977-05-09 1979-01-18
DE2912511C2 (en) * 1977-06-07 1982-06-24 Pfizer Inc., 10017 New York, N.Y. Pharmaceutical composition containing penicillanic acid
DK155942C (en) * 1977-12-23 1989-10-23 Pfizer METHOD OF ANALOGUE FOR THE PREPARATION OF 6-AMINOPENICILLANIC ACID-1,1-DIOXIDE AND PHYSIOLOGICALLY ACCEPTABLE ACID ADDITION AND BASIS SALTS.
JPS54126735A (en) * 1978-03-24 1979-10-02 Toyama Chem Co Ltd Bactericidal composition for medical use
US4241050A (en) * 1978-09-01 1980-12-23 Pfizer Inc. Penam 1,1-dioxides as beta-lactamase inhibitors
CA1158639A (en) * 1978-12-11 1983-12-13 Eric M. Gordon 6-bromopenicillanic acid sulfone
IE49880B1 (en) * 1979-02-13 1986-01-08 Leo Pharm Prod Ltd Penicillin derivatives
SE449103B (en) * 1979-03-05 1987-04-06 Pfizer SET TO PENICILLANIC ACID-1,1-DIOXIDE AND ESSERS THEREOF
US4714761A (en) * 1979-03-05 1987-12-22 Pfizer Inc. 6,6-dihalopenicillanic acid 1,1-dioxides and process
US4420426A (en) 1979-03-05 1983-12-13 Pfizer Inc. 6-Alpha-halopenicillanic acid 1,1-dioxides
GB2045236A (en) * 1979-03-26 1980-10-29 Hoechst Uk Ltd Oxapenem derivatives
US4309347A (en) 1979-05-16 1982-01-05 Pfizer Inc. Penicillanoyloxymethyl penicillanate 1,1,1',1'-tetraoxide
US4244951A (en) 1979-05-16 1981-01-13 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
IL59948A0 (en) * 1979-05-21 1980-06-30 Rech Applications Therap Penicillanic acid derivatives,their production and pharmaceutical compositions containing them
DE3051044C2 (en) * 1979-06-19 1989-03-30 Leo Pharmaceutical Products Ltd. A/S (Loevens Kemiske Fabrik Produktionsaktieselskab), Ballerup, Dk
US4256733A (en) * 1979-09-26 1981-03-17 Pfizer Inc. Acetoxymethyl penam compounds as β-lactamase inhibitors
US4432970A (en) * 1979-11-23 1984-02-21 Pfizer Inc. 6-beta-Halopenicillanic acid 1,1-dioxides as beta-lactamase inhibitors
IL61880A (en) * 1980-01-21 1984-11-30 Bristol Myers Co 2beta-chloromethyl-2alpha-methylpenam-3alpha-carboxylic acid sulfone derivatives,their preparation and pharmaceutical compositions containing them
US4432903A (en) * 1980-09-08 1984-02-21 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
US4488994A (en) * 1980-09-08 1984-12-18 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
US4474698A (en) * 1980-12-11 1984-10-02 Pfizer Inc. Process for preparing esters of penicillanic acid sulfone
US4419284A (en) * 1981-03-23 1983-12-06 Pfizer Inc. Preparation of halomethyl esters (and related esters) of penicillanic acid 1,1-dioxide
EP0069962B1 (en) * 1981-07-15 1985-01-02 Kanebo, Ltd. Novel ester of 1,1-dioxopenicillanic acid, process for production thereof, and use thereof as beta-lactamase inhibitor
PT76526B (en) * 1982-04-19 1986-01-21 Gist Brocades Nv Preparation of 6-alpha-bromo- and/or 6,6-dibromopenicillanic acid 1,1-dioxides
US4502988A (en) * 1983-08-08 1985-03-05 Eli Lilly And Company Oxidation process
EP0139047A1 (en) * 1983-10-18 1985-05-02 Gist-Brocades N.V. Process for the preparation of 6,6-dibromopenicillanic acid 1,1-dioxide
US4647457A (en) * 1983-12-16 1987-03-03 Hoffmann-La Roche Inc. Penicillanic acid derivatives
WO1987006230A1 (en) * 1986-04-10 1987-10-22 Leo Pharmaceutical Products Ltd. A/S Method for preparing penicillanic acid derivatives
GB8808701D0 (en) * 1988-04-13 1988-05-18 Erba Carlo Spa Beta-lactam derivatives
CN102977120B (en) * 2012-12-14 2015-05-27 江西富祥药业股份有限公司 Method for preparing and crystallizing sulbactam pivoxyl

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3197466A (en) * 1961-10-30 1965-07-27 Smith Kline French Lab Penicillin sulfoxides and process
LU77306A1 (en) * 1977-05-09 1979-01-18
AU3796278A (en) * 1977-07-13 1980-01-17 Glaxo Group Ltd Penams and azetidinones

Also Published As

Publication number Publication date
IE47079B1 (en) 1983-12-14
EG13869A (en) 1983-03-31
SU860706A1 (en) 1981-08-30
NO151746C (en) 1985-06-05
DD148585A5 (en) 1981-06-03
IT1096381B (en) 1985-08-26
CS208472B2 (en) 1981-09-15
IT7824270A0 (en) 1978-06-06
PH26810A (en) 1992-11-05
PL207396A1 (en) 1979-06-04
NL180009C (en) 1986-12-16
PL114501B1 (en) 1981-02-28
DE2824535C3 (en) 1981-01-22
DE2824535B2 (en) 1980-05-14
IL62168A0 (en) 1981-03-31
PH16465A (en) 1983-10-20
DE2857263C3 (en) 1981-12-17
AU513636B2 (en) 1980-12-11
AT360649B (en) 1981-01-26
AT364084B (en) 1981-09-25
ATA128580A (en) 1981-02-15
AR224111A1 (en) 1981-10-30
BE867859A (en) 1978-12-06
ATA411278A (en) 1980-06-15
DK155740C (en) 1989-10-23
NL930064I2 (en) 1994-04-18
DK251478A (en) 1978-12-08
DK155740B (en) 1989-05-08
FR2393804A1 (en) 1979-01-05
KE3355A (en) 1983-12-16
PH21116A (en) 1987-07-16
YU117078A (en) 1983-01-21
SE8305916L (en) 1983-10-27
NO152448B (en) 1985-06-24
DD140888A5 (en) 1980-04-02
SE436206B (en) 1984-11-19
BG34615A3 (en) 1983-10-15
IL54867A (en) 1981-11-30
IL54867A0 (en) 1978-08-31
NO781970L (en) 1978-12-08
FI781800A (en) 1978-12-08
YU41829B (en) 1988-02-29
FR2393805A1 (en) 1979-01-05
MY8500092A (en) 1985-12-31
SG65383G (en) 1985-03-29
HU180042B (en) 1983-01-28
IE781140L (en) 1978-12-07
FI66003C (en) 1984-08-10
DE2824535A1 (en) 1978-12-14
NO151746B (en) 1985-02-18
BG34614A3 (en) 1983-10-15
NL7806126A (en) 1978-12-11
PT68146A (en) 1978-07-01
NL930064I1 (en) 1993-09-01
FR2393805B1 (en) 1984-02-24
GR72255B (en) 1983-10-06
NO152448C (en) 1985-10-02
HK13184A (en) 1984-02-24
GB2000138A (en) 1979-01-04
FR2393804B1 (en) 1980-11-07
NO823126L (en) 1978-12-08
DE2857263B2 (en) 1981-04-23
NZ187476A (en) 1982-08-17
SE8305916D0 (en) 1983-10-27
IN149747B (en) 1982-04-03
SE7806628L (en) 1978-12-08
OA05964A (en) 1981-06-30
GB2000138B (en) 1982-03-03
CH634073A5 (en) 1983-01-14
SE447995B (en) 1987-01-12
FI66003B (en) 1984-04-30
LU79774A1 (en) 1980-01-22

Similar Documents

Publication Publication Date Title
AU513636B2 (en) Penicillanic acid 1,1-dioxides as beta-lactamase inhibitors
GB2081269B (en) Penicillanic acid derivatives
AU6306180A (en) Syn-7-(2-amino-4-thiazolyl) methoxyimino-acetamido -3- acetoxymethyl-3-cephem-4-carboxylic acid
AU523346B2 (en) Cephalosporanic acid derivatives
AU534754B2 (en) Penicillanic acid derivatives
AU517074B2 (en) 3 acetoxymethy-6-unsubstituted-penam compounds as beta- lactamase inhibitors
AU518781B2 (en) 7-OXO-l-AZABICYCLO 3. 2. 0 HEPT-2-ENE-2-CARBOXYLIC ACID DERIVATIVES
DK166353C (en) Penicillanic acid 1,1-dioxide DERIVATIVES
AU525132B2 (en) Beta-lactam compounds
AU3615678A (en) 6-azaoligocycloakyl-methylene amino-penicillanic acid derivatives
AU3553078A (en) O-aminodeoxyclayulanic acid derivatives
PH16933A (en) 6-amidino penicillanic acid derivatives including the radical of a beta-lactamase inhibitors
AU518620B2 (en) 7d-methoxy-7b-(1,3-dithietane-2-carboxamido)cephalosporanic acid derivatives
GB2051046B (en) Penicillanic acid derivatives
AU4689879A (en) Penicillanic acid derivative
AU3540678A (en) 2-trichloromethyl-4-nitrobenzenesulfenic acid derivatives
AU524795B2 (en) Beta-lactam series compound
AU511232B2 (en) Penicillins
AU533598B2 (en) Antibacterial penicillin derivatives
KE3489A (en) 7alpha-methoxy-7beta-(1,3-dithietane-2-carboxamido)cephalosporanic acid derivatives
GB2052981B (en) Penicillanic acid derivatives as -lactamose inhibitors
ZA782140B (en) Penicillanic acid 1,1-dioxides as b-lactamase inhibitors
ZA80880B (en) 6-beta-substituted penicillanic acids as beta-lactamase inhibitors
AU512826B2 (en) 6-ketenimine penicillin derivatives
SG55984G (en) Penicillanic acid derivatives